{"id":21616,"date":"2025-09-24T12:54:23","date_gmt":"2025-09-24T12:54:23","guid":{"rendered":"https:\/\/itbusinesstoday.com\/?p=21616"},"modified":"2025-09-24T12:54:23","modified_gmt":"2025-09-24T12:54:23","slug":"lantheus-and-ge-healthcare-partner-on-pylarify-in-japan","status":"publish","type":"post","link":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/lantheus-and-ge-healthcare-partner-on-pylarify-in-japan\/","title":{"rendered":"\u30e9\u30f3\u30c6\u30a6\u30b9\u3068GE\u30d8\u30eb\u30b9\u30b1\u30a2\u3001\u65e5\u672c\u306b\u304a\u3051\u308bPYLARIFY\u3067\u63d0\u643a"},"content":{"rendered":"<?xml encoding=\"utf-8\" ?><p>Lantheus Holdings, Inc. GE HealthCare and another company have signed an exclusive licensing deal. This agreement allows GE HealthCare to develop, make, and sell piflufolastat F 18 (known as PYLARIFY&reg; in the U.S.) in Japan. The PET imaging agent is now common in the U.S. and Europe. It helps find lesions that are positive for prostate-specific membrane antigen (PSMA) in men with prostate cancer. This agent is used for both diagnosis and as a companion diagnostic.<\/p><p>\u5408\u610f\u5185\u5bb9\u306f\u4e3b\u306b3\u70b9\uff1a<\/p><ul>\n<li>\u898f\u5236\u6587\u66f8\u306e\u8ee2\u9001<\/li>\n<li>\u88fd\u9020\u30ce\u30a6\u30cf\u30a6\u306e\u5171\u6709\u3002<\/li>\n<li>\u30e9\u30f3\u30c6\u30a6\u30b9\u304b\u3089GE\u30d8\u30eb\u30b9\u30b1\u30a2\u3078\u306e\u6280\u8853\u30b5\u30dd\u30fc\u30c8\u306e\u63d0\u4f9b\u3002<\/li>\n<\/ul><p>This partnership will help GE HealthCare expand clinical development in Japan. It sets the stage for regulatory submissions and a possible commercial launch. The initiative will tap into GE HealthCare&rsquo;s vast manufacturing and research network. This network got even stronger after it acquired Nihon Medi-Physics Co., Ltd. in March 2025. (NMP), a leading radiopharmaceutical company in Japan.<\/p><h4>\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a <a class=\"p-url\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/fujifilm-and-argenx-extend-collaboration-to-u-s-operations\/\" rel=\"bookmark\">\u5bcc\u58eb\u30d5\u30a4\u30eb\u30e0\u3068argenx\u3001\u7c73\u56fd\u3067\u306e\u5354\u696d\u3092\u62e1\u5927<\/a><\/h4><p>\u524d\u7acb\u817a\u304c\u3093\u306f\u4e16\u754c\u7684\u306b\u5927\u304d\u306a\u5065\u5eb7\u554f\u984c\u3067\u3059\u3002\u524d\u7acb\u817a\u304c\u3093\u306f\u3001\u4e16\u754c\u30674\u756a\u76ee\u306b\u591a\u3044\u304c\u3093\u3067\u3059\u30022022\u5e74\u306e\u524d\u7acb\u817a\u304c\u3093\u306e\u7f79\u60a3\u7387\u306f\u3001\u65e5\u672c\u304c\u7b2c3\u4f4d\u3002\u7c73\u56fd\u3068\u4e2d\u56fd\u3060\u3051\u304c\u591a\u3044\u30e9\u30a4\u30bb\u30f3\u30b9\u5951\u7d04\u3067\u306f\u3001GE\u30d8\u30eb\u30b9\u30b1\u30a2\u306f\u30e9\u30f3\u30c6\u30a6\u30b9\u306b\u5951\u7d04\u4e00\u6642\u91d1\u3092\u652f\u6255\u3044\u307e\u3059\u3002GE\u30d8\u30eb\u30b9\u30b1\u30a2\u306f\u30e9\u30f3\u30c6\u30a6\u30b9\u793e\u306b\u5951\u7d04\u4e00\u6642\u91d1\u3092\u652f\u6255\u3044\u3001\u958b\u767a\u30de\u30a4\u30eb\u30b9\u30c8\u30f3\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002\u30ed\u30a4\u30e4\u30ea\u30c6\u30a3\u306f\u65e5\u672c\u3067\u306e\u58f2\u4e0a\u9ad8\u306b\u3088\u308a\u307e\u3059\u3002\u4e21\u793e\u306f\u5171\u540c\u904b\u55b6\u59d4\u54e1\u4f1a\u3092\u8a2d\u7acb\u3059\u308b\u4e88\u5b9a\u3002\u3053\u306e\u30b0\u30eb\u30fc\u30d7\u306f\u958b\u767a\u3068\u5546\u696d\u5316\u306e\u52aa\u529b\u3092\u76e3\u7763\u3059\u308b\u4e88\u5b9a\u3002<\/p><p>Piflufolastat F 18, or 18F-DCFPyL, got FDA approval in 2021. Since then, it has become the leading PSMA PET imaging agent in the U.S. Marketed as PYLARIFY, it has aided over 500,000 patient scans in 48 states. This shows its clinical value in real-world settings. In 2023, the agent got approval in the European Union as PYLCLARI&trade;. Curium leads commercialization through a licensing deal with Progenics Pharmaceuticals, Inc., a Lantheus company.<\/p><p>\u3053\u306e\u65b0\u3057\u3044\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u306f\u91cd\u8981\u306a\u4e00\u6b69\u3067\u3059\u3002\u3053\u306e\u63d0\u643a\u306b\u3088\u308a\u3001\u5148\u9032\u7684\u306a\u524d\u7acb\u817a\u304c\u3093\u8a3a\u65ad\u304c\u65e5\u672c\u3067\u3082\u5229\u7528\u3057\u3084\u3059\u304f\u306a\u308a\u307e\u3059\u3002\u305d\u308c\u306f <a href=\"https:\/\/www.lantheus.com\/\" data-no-translation=\"\">Lantheus Holdings<\/a>&rsquo; advanced imaging technology with <a href=\"https:\/\/www.gehealthcare.com\/\" data-no-translation=\"\">&nbsp;GE HealthCare&nbsp;<\/a>&rsquo;s expertise in radiopharmaceuticals.<\/p>","protected":false},"excerpt":{"rendered":"<p>Lantheus Holdings, Inc. GE HealthCare and another company have signed an exclusive licensing deal. This agreement allows GE HealthCare to develop, make, and sell piflufolastat F 18 (known as PYLARIFY&reg; in the U.S.) in Japan. The PET imaging agent is now common in the U.S. and Europe. It helps find lesions that are positive for prostate-specific membrane antigen (PSMA) in men with prostate cancer. This agent is used for both diagnosis and as a companion diagnostic.The agreement covers three main points: Transferring regulatory dossiers. Sharing manufacturing know-how. Providing technical support from Lantheus to GE HealthCare. This partnership will help GE HealthCare expand clinical development in Japan. It sets the stage [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":21617,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[208,89,211,237,206],"tags":[2732,1363,8086,2730,8085],"ppma_author":[572],"class_list":["post-21616","post","type-post","status-publish","format-standard","has-post-thumbnail","category-apac","category-health-tech","category-japan","category-news","category-regional","tag-ge-healthcare","tag-health-tech","tag-lantheus","tag-pdx-segment","tag-piflufolastat-f-18"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Exclusive Japan License for PYLARIFY by Lantheus, GE<\/title>\n<meta name=\"description\" content=\"Lantheus and GE HealthCare sign an exclusive deal to develop PYLARIFY in Japan for advanced prostate cancer PET imaging.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/lantheus-and-ge-healthcare-partner-on-pylarify-in-japan\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Exclusive Japan License for PYLARIFY by Lantheus, GE\" \/>\n<meta property=\"og:description\" content=\"Lantheus and GE HealthCare sign an exclusive deal to develop PYLARIFY in Japan for advanced prostate cancer PET imaging.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/lantheus-and-ge-healthcare-partner-on-pylarify-in-japan\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-24T12:54:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/09\/Lantheus-and-GE-HealthCare-Announce-Exclusive-Licensing-Agreement-for-Prostate-Cancer-Imaging-Agent-PYLARIFY\u00ae-Piflufolastat-F-18-in-Japan.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"ITBT StaffWriter\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ITBT StaffWriter\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30e9\u30f3\u30c6\u30a6\u30b9\u793e\u3001GE\u793e\u306b\u3088\u308bPYLARIFY\u306e\u65e5\u672c\u306b\u304a\u3051\u308b\u72ec\u5360\u30e9\u30a4\u30bb\u30f3\u30b9\u306b\u3064\u3044\u3066","description":"\u30e9\u30f3\u30c6\u30a6\u30b9\u3068GE\u30d8\u30eb\u30b9\u30b1\u30a2\u3001\u524d\u7acb\u817a\u304c\u3093PET\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u7528PYLARIFY\u306e\u65e5\u672c\u306b\u304a\u3051\u308b\u72ec\u5360\u958b\u767a\u5951\u7d04\u3092\u7de0\u7d50.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/lantheus-and-ge-healthcare-partner-on-pylarify-in-japan\/","og_locale":"ja_JP","og_type":"article","og_title":"Exclusive Japan License for PYLARIFY by Lantheus, GE","og_description":"Lantheus and GE HealthCare sign an exclusive deal to develop PYLARIFY in Japan for advanced prostate cancer PET imaging.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/lantheus-and-ge-healthcare-partner-on-pylarify-in-japan\/","og_site_name":"itbusinesstoday","article_published_time":"2025-09-24T12:54:23+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/09\/Lantheus-and-GE-HealthCare-Announce-Exclusive-Licensing-Agreement-for-Prostate-Cancer-Imaging-Agent-PYLARIFY\u00ae-Piflufolastat-F-18-in-Japan.webp","type":"image\/webp"}],"author":"ITBT StaffWriter","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"ITBT StaffWriter","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/lantheus-and-ge-healthcare-partner-on-pylarify-in-japan\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/lantheus-and-ge-healthcare-partner-on-pylarify-in-japan\/"},"author":{"name":"ITBT StaffWriter","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15"},"headline":"Lantheus and GE HealthCare partner on PYLARIFY in Japan","datePublished":"2025-09-24T12:54:23+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/lantheus-and-ge-healthcare-partner-on-pylarify-in-japan\/"},"wordCount":353,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/lantheus-and-ge-healthcare-partner-on-pylarify-in-japan\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/09\/Lantheus-and-GE-HealthCare-Announce-Exclusive-Licensing-Agreement-for-Prostate-Cancer-Imaging-Agent-PYLARIFY\u00ae-Piflufolastat-F-18-in-Japan.webp","keywords":["GE HealthCare","Health tech","Lantheus","PDx segment","Piflufolastat F 18"],"articleSection":["APAC","Health Tech","Japan","News","Regional"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/lantheus-and-ge-healthcare-partner-on-pylarify-in-japan\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/lantheus-and-ge-healthcare-partner-on-pylarify-in-japan\/","name":"\u30e9\u30f3\u30c6\u30a6\u30b9\u793e\u3001GE\u793e\u306b\u3088\u308bPYLARIFY\u306e\u65e5\u672c\u306b\u304a\u3051\u308b\u72ec\u5360\u30e9\u30a4\u30bb\u30f3\u30b9\u306b\u3064\u3044\u3066","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/lantheus-and-ge-healthcare-partner-on-pylarify-in-japan\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/lantheus-and-ge-healthcare-partner-on-pylarify-in-japan\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/09\/Lantheus-and-GE-HealthCare-Announce-Exclusive-Licensing-Agreement-for-Prostate-Cancer-Imaging-Agent-PYLARIFY\u00ae-Piflufolastat-F-18-in-Japan.webp","datePublished":"2025-09-24T12:54:23+00:00","description":"\u30e9\u30f3\u30c6\u30a6\u30b9\u3068GE\u30d8\u30eb\u30b9\u30b1\u30a2\u3001\u524d\u7acb\u817a\u304c\u3093PET\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u7528PYLARIFY\u306e\u65e5\u672c\u306b\u304a\u3051\u308b\u72ec\u5360\u958b\u767a\u5951\u7d04\u3092\u7de0\u7d50.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/lantheus-and-ge-healthcare-partner-on-pylarify-in-japan\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/lantheus-and-ge-healthcare-partner-on-pylarify-in-japan\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/lantheus-and-ge-healthcare-partner-on-pylarify-in-japan\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/09\/Lantheus-and-GE-HealthCare-Announce-Exclusive-Licensing-Agreement-for-Prostate-Cancer-Imaging-Agent-PYLARIFY\u00ae-Piflufolastat-F-18-in-Japan.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/09\/Lantheus-and-GE-HealthCare-Announce-Exclusive-Licensing-Agreement-for-Prostate-Cancer-Imaging-Agent-PYLARIFY\u00ae-Piflufolastat-F-18-in-Japan.webp","width":1200,"height":800,"caption":"Lantheus"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/lantheus-and-ge-healthcare-partner-on-pylarify-in-japan\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"Lantheus and GE HealthCare partner on PYLARIFY in Japan"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15","name":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png90b3cb23d1d9c08733d969d29ea2d30d","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","caption":"ITBT StaffWriter"},"description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002","sameAs":["https:\/\/itbusinesstoday.com\/"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/itbt-staffwriter\/"}]}},"authors":[{"term_id":572,"user_id":7,"is_guest":0,"slug":"itbt-staffwriter","display_name":"ITBT StaffWriter","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png"},"author_category":"","first_name":"ITBT","last_name":"StaffWriter","user_url":"https:\/\/itbusinesstoday.com\/","job_title":"","description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002"}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/21616","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=21616"}],"version-history":[{"count":3,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/21616\/revisions"}],"predecessor-version":[{"id":21645,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/21616\/revisions\/21645"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/21617"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=21616"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=21616"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=21616"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=21616"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}